Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ultragenyx Pharmaceutical Inc. (RARE) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / July 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or "the Company") (NASDAQ:RARE). Investors who purchased Ultragenyx securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RARE. […]